Adicet Bio, Inc. — Form 10-Q
Filed August 5, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 12/100
What the filing says
Adicet Bio amended its Non-Employee Director Compensation Policy effective June 21, 2026. The policy sets cash retainers (board membership $40,000 annually, committee chair/member fees $4,000–$15,000) and equity awards (initial grant of 8,400 options to new directors, 4,200 annual options to continuing directors). No material changes to compensation amounts or share quantities are disclosed in this amendment.
Why this rating
Routine governance update with no disclosed changes to dollar amounts or equity grants; immaterial relative to $50.5M market cap.
See more from August 5, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.